89bio, Inc. - Common stock, par value $0.001 per share (ETNB)
CUSIP: 282559103
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common stock, par value $0.001 per share
- Shares outstanding
- 148,275,293
- Total 13F shares
- 121,178,976
- Share change
- +16,359,642
- Total reported value
- $947,691,955
- Put/Call ratio
- 1243%
- Price per share
- $7.82
- Number of holders
- 152
- Value change
- +$128,680,752
- Number of buys
- 95
- Number of sells
- 54
Quarterly Holders Quick Answers
What is CUSIP 282559103?
CUSIP 282559103 identifies ETNB - 89bio, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 282559103:
Top shareholders of ETNB - 89bio, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
10%
|
15,158,218
|
$112,139,811 | — | 30 Sep 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
9.6%
|
14,175,398
|
$104,897,945 | — | 30 Sep 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.4%
|
7,991,644
|
$59,138,166 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.1%
|
7,549,302
|
$55,864,834 | — | 30 Sep 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
5%
|
7,378,548
|
$54,601,255 | — | 30 Sep 2024 | |
| BVF INC/IL |
13F
|
Company |
4.6%
|
6,811,631
|
$50,406,069 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
5,006,277
|
$37,046,450 | — | 30 Sep 2024 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
3.6%
|
4,333,885
|
$29,903,806 | $0 | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
3,251,687
|
$24,062,484 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.2%
|
3,246,608
|
$24,024,899 | — | 30 Sep 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
2%
|
3,006,038
|
$22,244,681 | — | 30 Sep 2024 | |
| ORBIMED ADVISORS LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,829,436
|
$21,093,397 | — | 25 Jan 2022 | |
| Deep Track Capital, LP |
13F
|
Company |
1.9%
|
2,766,512
|
$20,472,189 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
2,556,727
|
$18,919,780 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
2,074,970
|
$15,357,607 | — | 30 Sep 2024 | |
| Redmile Group, LLC |
13F
|
Company |
1.1%
|
1,569,850
|
$11,616,890 | — | 30 Sep 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.67%
|
1,000,000
|
$7,400,000 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.59%
|
875,000
|
$6,475,000 | — | 30 Sep 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.59%
|
871,404
|
$6,448,000 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.57%
|
848,079
|
$6,275,503 | — | 30 Sep 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.55%
|
810,533
|
$5,997,944 | — | 30 Sep 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.55%
|
808,564
|
$5,983,374 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
794,712
|
$5,880,869 | — | 30 Sep 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.51%
|
763,000
|
$5,631,265 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.49%
|
733,497
|
$5,427,878 | — | 30 Sep 2024 | |
| University of Wisconsin Foundation |
13F
|
Company |
0.49%
|
724,132
|
$5,358,577 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
721,050
|
$5,335,770 | — | 30 Sep 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.4%
|
595,203
|
$4,404,502 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.4%
|
587,062
|
$4,344,259 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.34%
|
504,563
|
$3,991,093 | — | 30 Sep 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.36%
|
536,547
|
$3,970,448 | — | 30 Sep 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.34%
|
500,000
|
$3,700,000 | — | 30 Sep 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.32%
|
470,387
|
$3,480,864 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.29%
|
435,298
|
$3,221,205 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.27%
|
400,238
|
$2,961,765 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
381,981
|
$2,826,659 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.25%
|
368,688
|
$2,728,291 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.23%
|
340,071
|
$2,516,525 | — | 30 Sep 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.22%
|
330,000
|
$2,442,000 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.22%
|
325,707
|
$2,410,233 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.22%
|
319,045
|
$2,360,933 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.21%
|
312,024
|
$2,308,978 | — | 30 Sep 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.2%
|
300,600
|
$2,224,440 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.2%
|
289,912
|
$2,145,349 | — | 30 Sep 2024 | |
| Caption Management, LLC |
13F
|
Company |
0.17%
|
255,200
|
$1,888,480 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
241,504
|
$1,787,130 | — | 30 Sep 2024 | |
| Newtyn Management, LLC |
13F
|
Company |
0.16%
|
240,000
|
$1,776,000 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
238,842
|
$1,767,431 | — | 30 Sep 2024 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.15%
|
227,930
|
$1,687,000 | — | 30 Sep 2024 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.15%
|
227,953
|
$1,686,852 | — | 30 Sep 2024 |
Institutional Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q4 2024
As of 31 Dec 2024,
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) was held by
152 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
121,178,976 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock, Inc., RTW INVESTMENTS, LP, Deep Track Capital, LP, VANGUARD GROUP INC, CITADEL ADVISORS LLC, BVF INC/IL, and Avoro Capital Advisors LLC.
This page lists
152
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
142
Q4 2024 holders
152
Holder diff
10
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.